Praxis Precision Medicines Inc Live Stock Price Today, Share Analysis and Chart

Name: Praxis Precision Medicines Inc: Is Infosys Ltd. worth buying?
Item: Praxis Precision Medicines Inc
Rating: 1.36833325
Author: Trendlyne DVM scores

about

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal ...

42.22 -3.01 (-6.65%)

54.02% Fall from 52W High

625.7K

XNAS Volume

XNAS 19 Sep, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

11.3 / 100

Technically Neutral

43.4 / 100

100

1Yr Price target upside is 137%

14 analysts

Praxis Precision Medicines Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Praxis Precision Medicines Inc Live Stock Price Today, Share Analysis and Chart

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal ...

54.02% Fall from 52W High

SWOT Analysis

Praxis Precision Medicines Inc Live Price Chart